Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13566377 | 0.78 | — | — | |
| SCHEMBL13982874 | 0.78 | — | — | |
| SCHEMBL15820692 | 0.76 | — | — | |
| SCHEMBL2600751 | 0.70 | — | — | |
| SCHEMBL18214836 | 0.69 | LMNA (0.33) | LMNA | |
| SCHEMBL10367498 | 0.68 | TDP1 (0.38) | LMNA | |
| SCHEMBL22759757 | 0.67 | — | — | |
| SCHEMBL21240709 | 0.67 | — | — | |
| SCHEMBL16305901 | 0.64 | GRIA1 (0.33) | — | |
| SCHEMBL31530780 | 0.64 | LMNA (0.31) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8940856-B2 | Heterocyclic compound and heterocyclic polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-01-27 | — | — | US | disclosed |
| US-8940856-B2 | Heterocyclic compound and heterocyclic polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-01-27 | — | — | US | disclosed |
| US-20090318651-A1 | HETEROCYCLIC COMPOUND AND HETEROCYCLIC POLYMERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318651-A1 | HETEROCYCLIC COMPOUND AND HETEROCYCLIC POLYMERS | H1-3, H1-2, H1-5 | LMNA 1927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.